C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
Authors:
- Konstanze MichelKMKonstanze Michel
- Melissa HerwigMHMelissa Herwig
- Franziska WernerFWFranziska Werner
- Katarina Špiranec SpesKSKatarina Špiranec Spes
- Marco AbeßerMAMarco Abeßer
- Kai SchuhKSKai Schuh
- Swati DabralSwati Dabral
- Andreas MüggeAMAndreas Mügge
- Hideo A. BabaHBHideo A. Baba
- Boris V. SkryabinBSBoris V. Skryabin
- Nazha HamdaniNHNazha Hamdani
- Michaela KuhnMKMichaela Kuhn
Open Access
- 19 November 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (22)
Abstract
Heart failure is often accompanied by titin-dependent myocardial stiffness. Phosphorylation of titin by cGMP-dependent protein kinase I (PKGI) increases cardiomyocyte distensibility. The upstream pathways stimulating PKGI-mediated titin phosphorylation are unclear. We studied whether C-type natriuretic peptide (CNP), via its guanylyl cyclase-B (GC-B) receptor and cGMP/PKGI signaling, modulates titin-based ventricular compliance. To dissect GC-B–mediated effects of endogenous CNP in cardiomyocytes, we generated mice with cardiomyocyte-restricted GC-B deletion (CM GC-B–KO mice). The impact on heart morphology and function, myocyte passive tension, and titin isoform expression and phosphorylation was studied at baseline and after increased afterload induced by transverse aortic constriction (TAC). Pressure overload increased left ventricular endothelial CNP expression, with an early peak after 3 days. Concomitantly, titin phosphorylation at Ser 4080 , the site phosphorylated by PKGI, was augmented. Notably, in CM GC-B–KO mice this titin response was abolished. TAC-induced hypertrophy and fibrosis were not different between genotypes. However, the KO mice presented mild systolic and diastolic dysfunction together with myocyte stiffness, which were not observed in control littermates. In vitro, recombinant PKGI rescued reduced titin-Ser 4080 phosphorylation and reverted passive stiffness of GC-B–deficient cardiomyocytes. CNP-induced activation of GC-B/cGMP/PKGI signaling in cardiomyocytes provides a protecting regulatory circuit preventing titin-based myocyte stiffening during early phases of pressure overload.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG KU 1037/7-1)
This publication has 44 references indexed in Scilit:
- Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human heartsCardiovascular Research, 2013
- Crucial Role for Ca 2+ /Calmodulin-Dependent Protein Kinase-II in Regulating Diastolic Stress of Normal and Failing Hearts via Titin PhosphorylationCirculation Research, 2013
- Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fractionCardiovascular Research, 2012
- Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac RemodelingInternational Journal of Vascular Medicine, 2012
- Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase IEuropean Heart Journal, 2011
- PKC Phosphorylation of Titin’s PEVK ElementCirculation Research, 2009
- Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin SpringsCirculation Research, 2009
- Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection FractionCirculation, 2008
- CNP infusion attenuates cardiac dysfunction and inflammation in myocarditisBiochemical and Biophysical Research Communications, 2007
- C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarctionJACC, 2005